169 related articles for article (PubMed ID: 27654453)
1. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
Chung YS; Lee JH; Lee YD
Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
[TBL] [Abstract][Full Text] [Related]
2. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
[TBL] [Abstract][Full Text] [Related]
3. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
4. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
Dong Z; Liu W; Su F; Cheng R
Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
[TBL] [Abstract][Full Text] [Related]
5. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
6. Association Between Obesity and BRAFV600E Mutation Status in Patients with Papillary Thyroid Cancer.
Lee J; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Jung SG; Lee EJ; Chung WY; Jo YS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S683-90. PubMed ID: 26215201
[TBL] [Abstract][Full Text] [Related]
7. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
8. [Association between body mass index and aggressiveness of papillary thyroid carcinoma].
Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R
Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539
[TBL] [Abstract][Full Text] [Related]
9. The influence of body mass index on the diagnostic performance of pre-operative staging ultrasound in papillary thyroid carcinoma.
Choi JS; Lee HS; Kim EK; Moon HJ; Kwak JY
Clin Endocrinol (Oxf); 2015 Oct; 83(4):550-5. PubMed ID: 25323560
[TBL] [Abstract][Full Text] [Related]
10. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.
Kim M; Kang YE; Park YJ; Koo BS; Ku EJ; Choi JY; Lee EK; Kim BH
Endocrine; 2023 Oct; 82(1):134-142. PubMed ID: 37516686
[TBL] [Abstract][Full Text] [Related]
11. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
[TBL] [Abstract][Full Text] [Related]
12. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390
[TBL] [Abstract][Full Text] [Related]
13. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
15. Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer.
Kim SH; Park HS; Kim KH; Yoo H; Chae BJ; Bae JS; Jung SS; Song BJ
Surg Today; 2015 Jun; 45(6):723-9. PubMed ID: 25059345
[TBL] [Abstract][Full Text] [Related]
16. Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer.
Shi RL; Qu N; Liao T; Wei WJ; Lu ZW; Ma B; Wang YL; Ji QH
Tumour Biol; 2016 Jun; 37(6):8383-90. PubMed ID: 26733165
[TBL] [Abstract][Full Text] [Related]
17. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.
Pinto AE; Silva GL; Henrique R; Menezes FD; Teixeira MR; Leite V; Cavaco BM
Eur J Endocrinol; 2014 Feb; 170(2):321-7. PubMed ID: 24272198
[TBL] [Abstract][Full Text] [Related]
18. Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract][Full Text] [Related]
19. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
